Juliusz Krzyżanowski
Baker McKenzie Krzyzowski i Wspólnicy Sp.k.Noted for its ‘outstanding performance’, the team at Baker McKenzie Krzyzowski i Wspólnicy Sp.k. is recommended for its vast knowledge of reimbursement issues and drug approval procedures. The group is also well-equipped to advise on distribution schemes. Praised by clients for providing ’superb service and unrivalled sectoral insights', practice head Juliusz Krzyżanowski is an expert in matters involving clinical trials, advertising, and investments into the healthcare space. Marcin Fiałka is adept at handling data privacy issues, with a strong focus on pharmaceutical market regulations and data processing work.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
'The Baker McKenzie Pharmaceutical team are not only regulatory experts with in-depth knowledge of pharmaceutical and reimbursement regulations. They are also excellent negotiators, and one can see their practical corporate background. They are familiar with market trends from the inside out. In this particular transaction everything was in a perfect setup and knew that we are in good hands.’
‘I work with Juliusz Krzyżanowski, who is trustworthy advisor with an objective view on the issues involved in a particular case. He always tries to fit our needs into legal possibilities. He is knowledgeable and has entire understanding of the business. Provides proposals to the point.’
‘Proactive engagement, incredibly responsive, sectoral knowledge and expertise.’
‘Juliusz Krzyżanowski provides excellent advice, a superb service and unrivalled sectoral insights.’
‘Under the guidance of Juliusz Krzyżanowski, a legal counsel based in Poland, they have consistently demonstrated strong performance and accuracy in their assigned tasks, delivering on time, and good knowledge of the healthcare industry. I would also like to highlight the effective coordination among these jurisdictions, ensuring a uniform quality in their outputs.’
‘Baker McKenzie has been involved in a variety of projects, including those related to antitrust, commercial, regulatory, and contractual matters, demonstrating outstanding performance. Notably, they have provided legal services for significant projects impacting Ukraine, navigating the ever-changing circumstances and new, complex regulations affecting companies and their employees.'
‘Baker McKenzie Krzyzowski i Wspólnicy Sp.k. distinguishes itself through its innovative approach to client service. The firm prioritises personalised attention, ensuring that each client's needs are met with tailored solutions. The team's deep understanding of both the legal landscape and the specific industries it serves allows it to offer comprehensive and strategic advice.'
‘The team stands out due to its unwavering commitment to client satisfaction and their ability to deliver innovative legal solutions. Each member of the team possesses a deep understanding of their respective legal domains, coupled with a genuine dedication to addressing client needs.'
Key clients
- 3M
- AbbVie
- Alnylam Pharmaceuticals
- Ascensia Diabetes Care
- Astellas Pharma
- Baxter
- BeiGene
- Berlin-Chemie
- Menarini
- Bristol-Myers Squibb
- CSL Behring
- Eli Lilly
- Lundbeck Poland
- MSD
- Novo Nordisk
- PTC Therapeutics
- Swedish Orphan Biovitrum
- UCB Pharma
- Zimmer Biomet
- Takeda Pharma
- Thea Pharma
- Theramex
- Regeneron
- Izba Gospodarcza
- American Chamber of Commerce
Work highlights
- Advised Isba Gospodarcza on the legislative process regarding the amendment to the Polish Act on Reimbursement.
Lawyers
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Practice head
The lawyer(s) leading their teams.
Juliusz Krzyżanowski